Eleven studies enrolled patients with CRC of UICC stages I–IV, 1 study investigated survivin expression only in UICC stage III CRC and the remaining 3 studies did not provide any information regarding the UICC stage. This evidence concerns the gene BIRC5 and colorectal carcinoma.